Stock Track | Nuvation Bio Plummets 25.26% Intraday on Earnings Miss and Analyst Downgrade

Stock Track
03/03

Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.

The sharp drop follows the company's recent fourth-quarter earnings report, which revealed a loss of $0.11 per share. This result missed the analyst consensus estimate of a $0.09 loss by 22.22%, disappointing investors despite the company's quarterly sales surpassing expectations.

Adding to the negative sentiment, UBS adjusted its price target on Nuvation Bio downward to $7 from $10 while maintaining a Neutral rating. The combination of an earnings miss and a reduced price target from a major analyst firm contributed to the severe sell-off in the stock.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10